Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1269, 2001-01, pp. : 17-17
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Alemtuzumab superior to chlorambucil for front-line CLL therapy
Inpharma, Vol. 1, Iss. 1574, 2007-01 ,pp. :
Fludarabine + cyclophosphamide effective for CLL
Inpharma, Vol. 1, Iss. 1598, 2007-01 ,pp. :
Chlorambucil beats fludarabine regimen in advanced FCCL
Inpharma, Vol. 1, Iss. 1571, 2007-01 ,pp. :
Oral fludarabine: a first-line option for CLL
Inpharma, Vol. 1, Iss. 1374, 2003-01 ,pp. :